AI-generated summary
The authors report a pilot randomized open-label trial of morning bright light therapy in 14 adults with insomnia over two weeks. Within the light therapy group, sleepiness, insomnia and sleep quality scores improved, but only the sleepiness change differed significantly from control, and cortisol and clock gene levels did not differ. The authors state that further well-designed studies are needed to confirm efficacy.
- Participants
- 14
- Who or what was studied
- Adults aged 20-60 years with insomnia
- Wavelengths
- 480 nm
- Limits stated in the abstract
- The abstract describes a small pilot study with open-label design, so participants knew their group, and the authors state further well-designed studies are needed to confirm efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background And Objectives
Light therapy (LT) is used as an adjunctive treatment for sleep problems. This study evaluates the impact of LT on sleep quality and sleep-related parameters in patients with sleep disorders.
Materials And Methods
We performed a pilot, randomized, open-label clinical trial. Fourteen patients aged 20-60 years with insomnia were randomized into the control and LT groups (1:1 ratio). The LT group was instructed to use a device that provides bright LT (6000 K, 380 lux, wavelength 480 nm) for at least 25 min before 09:00 a.m. for two weeks. A self-reported questionnaire was used to evaluate circadian preference, mood, and sleep-related parameters. We analyzed serum cortisol levels and clock genes' expression.
Results
The Epworth Sleepiness Scale (ESS), insomnia severity index(ISI), and Pittsburgh Sleep Quality index(PSQI) were significantly improved within the LT group only after the two-week period. When comparing the two groups, only the change in ESS was significant (mean difference, control: -0.14 vs. LT: -1.43, p = 0.021) after adjusting for the baseline characteristics. There were no significant differences in serum cortisol or clock genes' expression.
Conclusions
LT can improve daytime sleepiness in patients with sleep disorders; however, further well-designed studies are warranted to confirm its efficacy.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 480 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Insomnia, Wavelength, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.